BioLife Solutions, Inc. Earnings Per Share (Diluted)
BioLife Solutions, Inc. (BLFS) reported Earnings Per Share (Diluted) of $0.91 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- BioLife Solutions, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was $0.91.
- BioLife Solutions, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.02.
- BioLife Solutions, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.01.
- BioLife Solutions, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.33.
- BioLife Solutions, Inc. earnings per share, diluted for fiscal 2025 was -$0.10.
- BioLife Solutions, Inc. earnings per share, diluted for fiscal 2024 was -$0.44.
- BioLife Solutions, Inc. earnings per share, diluted for fiscal 2023 was -$1.55.
- BioLife Solutions, Inc. earnings per share, diluted for fiscal 2022 was -$3.25.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.91 10-Q · filed 2026-08-06 | $0.94 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $0.02 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | -$0.10 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-06 | -$0.33 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$0.33 10-Q · filed 2026-08-06 | -$0.34 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$0.01 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | -$0.44 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | -$0.04 10-Q · filed 2025-11-06 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.71 10-Q · filed 2025-11-06 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-02-26 | ||||
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-07 | -$0.68 10-Q · filed 2025-08-07 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-02-26 | ||||
| 2024-03-31 | -$0.22 10-Q · filed 2025-05-08 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-02-26 | ||||
| 2023-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.55 10-K · filed 2026-02-26 | -$1.52 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$0.67 10-Q · filed 2024-11-12 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.22 10-Q · filed 2024-11-12 | -$2.33 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||||
| 2023-06-30 | -$0.23 10-Q · filed 2024-08-09 | -$0.55 10-Q · filed 2024-08-09 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.91 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||||
| 2023-03-31 | -$0.32 10-Q · filed 2024-05-10 | -$1.43 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.68 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$3.37 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||||
| 2022-12-31 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.36 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$3.05 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$3.25 10-K · filed 2025-03-03 | -$3.29 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$0.24 10-Q · filed 2023-11-09 | -$0.23 10-Q · filed 2022-11-09 | -$1.96 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.14 10-Q · filed 2023-11-09 | -$2.11 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | -$1.72 10-Q · filed 2023-08-09 | -$1.71 10-Q · filed 2022-08-09 | -$1.90 10-Q · filed 2023-08-09 | -$1.89 10-Q · filed 2022-08-09 | ||||
| 2021-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.23 10-K · filed 2024-02-29 | -$0.20 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.19 derived: net income ÷ weighted average shares · filed 2022-11-09 | $0.17 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $0.19 10-Q · filed 2022-08-09 | $0.17 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$0.03 10-Q · filed 2021-05-17 | |||||||
| 2020-12-31 | -$0.06 10-K · filed 2023-03-31 | -$0.03 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | -$0.04 10-Q · filed 2021-11-15 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-11-15 | $0.01 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$0.70 10-Q · filed 2021-08-16 | $0.01 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$0.01 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$0.09 10-K · filed 2022-03-31 | |||||||
| 2019-09-30 | $0.35 10-Q · filed 2020-11-09 | $0.37 10-Q · filed 2019-11-12 | $0.38 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.24 10-Q · filed 2020-11-09 | $0.43 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $0.02 10-Q · filed 2020-08-10 | $0.03 10-Q · filed 2019-08-09 | -$0.80 10-Q · filed 2020-08-10 | $0.05 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | -$1.03 10-Q · filed 2020-05-29 | $0.02 10-Q · filed 2019-05-09 | ||||||
| 2018-12-31 | -$1.56 10-K · filed 2020-05-15 | $0.14 10-K · filed 2019-03-15 | ||||||
| 2018-09-30 | -$1.42 10-K · filed 2020-05-15 | $0.05 10-Q · filed 2018-11-08 | -$3.14 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$2.98 10-K · filed 2020-05-15 | $0.10 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | -$1.74 10-K · filed 2020-05-15 | $0.05 10-Q · filed 2018-08-09 | -$1.48 10-K · filed 2020-05-15 | $0.05 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | -$0.02 10-K · filed 2020-05-15 | -$0.01 10-Q · filed 2019-05-09 | ||||||
| 2017-12-31 | -$0.21 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | -$0.03 10-Q · filed 2018-11-08 | -$0.16 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$0.06 10-Q · filed 2018-08-09 | -$0.13 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |